We describe the first case of drug-induced solar urticaria due to repirinast, an antiallergic drug developed and introduced into the market in Japan in 1987. The patient was a 72-year-old woman who had been on repirinast for 1 year and 8 months. She developed urticaria immediately after an irradiation with 1.5 J/cm2 of UVA, and the provocation test confirmed that repirinast was responsible for the urticarial reaction. The action spectrum of the urticarial reaction was deduced to be 320-350 nm. Passive and reverse passive transfer test results were both negative. However, intradermal injection of patient serum, obtained while she was on repirinast and irradiated in vitro with UVA, demonstrated positive reactions both in the patient and in a normal volunteer. Our findings suggest that nonallergic mechanisms are involved in the reaction. However, the rarity of the phenomenon also suggests an association with some allergic mechanisms.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000247114 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Photoprotection and its implications for drug safety].
Med Pr
November 2024
Uniwersytet Jagielloński Collegium Medicum / Jagiellonian University Medical College, Kraków, Polska (Wydział Farmaceutyczny, Katedra Chemii Nieorganicznej i Analityki Farmaceutycznej / Faculty of Pharmacy, Department of Inorganic and Pharmaceutical Analytics).
Appropriate photoprotection plays a key role in the safety of using medicinal preparations whose active substances may induce photosensitivity reactions. This aspect applies not only to drugs applied topically to the skin, but also systemically. Drug-induced photosensitivity reactions to light depend on the active substance contained in the medicinal product and its dose, which translates into the concentration in the skin, the type of ultraviolet radiation, its intensity and exposure time.
View Article and Find Full Text PDFSolar retinopathy related to antidepressant use in a patient with major depressive disorder: a case report.
J Yeungnam Med Sci
July 2024
Department of Psychiatry, Yeungnam University College of Medicine, Daegu, Korea.
This case report is a unique case of solar retinopathy following antidepressant-induced mydriasis and highlights the need for comprehensive ophthalmic evaluation in patients treated with medications having mydriatic effects. A 49-year-old female patient who had received long-term antidepressant therapy presented with bilateral visual impairment after prolonged sun exposure. Fundoscopy confirmed solar retinopathy, which was attributed to drug-induced mydriasis.
View Article and Find Full Text PDFNITROSAMINES IN COMMONLY PRESCRIBED ANTIHYPERTENSIVES AND THE (UN)CONTROLLED DRUG-INDUCED SKIN CANCER: SIMULTANEOUS DEVELOPMENT OF CUTANEOUS MELANOMA AND MULTIPLE BCC AFTER CONCOMITANT ADMINISTRATION OF BISOPROLOL AND FUROSEMIDE.
Georgian Med News
September 2023
Onkoderma - Clinic for Dermatology, Venereology and Dermatologic Surgery, Sofia; Department of Dermatology and Venereology, Medical Institute of Ministry of Interior, Sofia, Bulgaria.
The era of nitrosogenesis is the era that is conditioned by the permanent and prolonged intake of carcinogens/mutagens, also known as nitrosamines/NDSRIs in the context of polymedication/polycontamination in polymorbid patients. Until recently, the favoured and universally accepted thesis by the scientific community that polymorbidity determines the risk of developing cancer has been shown to be weakly substantiated and superseded by the more modern notion that: it is the polycontamination with carcinogens in the context of concomitant medication/ polymorbidity that determines to a large extent the risk of developing heterogeneous cancers, including skin cancer: keratinocytic and melanocytic. The FDA is the organization that first pulled back the curtain on the backstage back in 2018 on this topic.
View Article and Find Full Text PDFFixed Sunlight Eruption: A Series of 13 Cases in Bogotá, Columbia.
Actas Dermosifiliogr
March 2024
Fundación Santafé de Bogotá, Bogotá, Colombia.
Article Synopsis
- * A study involved 13 patients, predominantly women, aged 28 to 56, who experienced these eruptions at a dermatology referral hospital in Bogotá, Colombia.
- * The lesions appeared in specific areas of the body and were confirmed through photoprovocation and histopathology, suggesting a potential link to fixed drug eruptions, although they might represent a different condition with a similar cause.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!